Skip to content

Clinical trials

Observational Carotid Stenosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carotid Stenosis Phase: Observational Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20061
20077
20081
20104
201110
20126
20138
20144
20156
20161
20176
20186
201911
202010
202113
202217
202312
20244
202511
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Unknown status39
Recruiting27
Not yet recruiting7
Active, not recruiting5
Terminated5
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing5
National Heart, Lung, and Blood Institute (NHLBI)4
Second Affiliated Hospital, Zhejiang University, School of Medicine4
AstraZeneca3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
John Paul II Hospital, Krakow3
Radboud University Medical Center3
Silk Road Medical3
Universidade do Porto3
Beijing Tiantan Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carotid Stenosis156
Carotid Artery Diseases25
Stroke25
Atherosclerosis20
Ischemic Stroke20
Ischemic Attack, Transient9
Diabetes Mellitus8
Cardiovascular Diseases7
Coronary Artery Disease6
Peripheral Arterial Disease6

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.